Abstract:Using dehydroabietic acid as the lead compound for structural modification, 25 dehydroabietic acid derivatives were synthesized. Among them, compound D1 not only showed the strongest relaxation effect on the aortic vascular ring in vitro (Emax = 99.5 ± 2.1%, EC50 = 3.03 ± 0.96 µM), but also significantly reduced systolic and diastolic blood pressure in rats at a dose of 2.0 mg/kg in vivo. Next, the vascular protective effect of the best active D1 and its molecular mechanism were further investigated by HUVECs. The results showed that D1 induced endothelium-dependent diastole in the rat thoracic aorta in a concentration-dependent manner. Endothelium removal or aortic ring pretreatment with NG-nitro-l-arginine methylester (l-NAME), 1H-[1,2,4]-oxadiazolo-[4,3-a]-quinoxalin-1-one (ODQ), and tetraethylammonium (TEA) significantly inhibited D1-induced relaxation. In addition, wortmannin, KT5823, triciribine, diltiazem, BaCl2, 4-aminopyridine, indomethacin, propranolol, and atropine attenuated D1-induced vasorelaxation. D1 increased the phosphorylation of eNOS in HUVECs Furthermore, D1 attenuated the expression of TNF-α-induced cell adhesion molecules such as ICAM-1 and VCAM-1. However, this effect was attenuated by the eNOS inhibitors l-NAME and asymmetric dimethylarginine (ADMA). The findings suggest that D1-induced vasorelaxation through the PI3K/Akt/eNOS/NO/cGMP/PKG pathway by activating the KCa, Kir and KV channels or muscarinic and β-adrenergic receptors, and inhibiting the l-type Ca2+ channels, which is closely related to the hypotensive action of the agent. Furthermore, D1 exhibits an inhibitory effect on vascular inflammation, which is associated with the observed vascular protective effects.

Design, Synthesis, and Vasorelaxation Activity of Novel Imperatorin Derivatives.

Design, synthesis and preliminary evaluation of novel imperatorin derivatives as vasorelaxant agents.

Design, Synthesis, and Evaluation of New Series of Imperatorin Analogs with Potential Vasodilatory Activity

Research on the synthesis and vasodilatation activity of imperatorin derivatives

Synthesis and Vasorelaxation Evaluation of Novel Biphenyl–furocoumarin Derivatives

Synthesis and Biological Evaluation of Novel Biphenyl-Furocoumarin Derivatives As Vasodilator Agents

Synthesis and Vasorelaxant Evaluation of Novel 7-Methoxyl-2,3-disubstituted-quinoxaline Derivatives

Design, Synthesis and Evaluation of 9-Hydroxy-7h-furo[3,2-g]chromen-7-one Derivatives As New Potential Vasodilatory Agents

Design and Synthesis of Novel Xyloketal Derivatives and Their Vasorelaxing Activities in Rat Thoracic Aorta and Angiogenic Activities in Zebrafish Angiogenesis Screen

Design of Novel Thiazole Bearing Pyrazole Derivatives and Their Dual Activities as ACE Inhibitors and Calcium Channel Blockers in Cardiovascular Disease

Discovery of Novel 2-Benzylisoquinolin-1(2h)-ones As Potent Vasodilative Agents

Design, synthesis and biological evaluation of dehydroabietic acid derivative as potent vasodilatory agents

Synthesis and Vasorelaxant Activity of Benzopyran-4-thioureas

Synthesis and biological evaluation of novel hybrid chalcone derivatives as vasorelaxant agents.

Discovery of Novel 3-Benzylquinazolin-4(3 H )-Ones As Potent Vasodilative Agents

Flavonoids As Vasorelaxant Agents: Synthesis, Biological Evaluation and Quantitative Structure Activities Relationship (qsar) Studies

Synthesis and Vascular Relaxing Activity of Arecoline Derivatives Coupled with Nitric Oxide Donors

[Design, Synthesis and Vasorelaxant Activity of R, S-1-(substituted Phenyl)-4-[3-(naphtha-1-yl-oxy)-2-hydroxypropyl]-piperazine Derivatives].

Synthesis of potent vasodilating agents: in silico and in vitro evaluation of 6-(4-substitutedphenyl)-3-pyridazinone derivatives as potential hydralazine analogues

Synthesis and Biological Evaluation of Vinpocetine Derivatives

Synthesis, biological evaluation and quantitative structure-activities relationship of flavonoids as vasorelaxant agents.